Comparison of 2-hour postprandial blood glucose excursion in response to a standard test meal in insulin-requiring diabetic patients treated twice daily with either insulin lispro mix 50/50 [insulin lispro] or human insulin mix 50/50 [insulin neutral protamine lispro/insulin lispro]

Trial Profile

Comparison of 2-hour postprandial blood glucose excursion in response to a standard test meal in insulin-requiring diabetic patients treated twice daily with either insulin lispro mix 50/50 [insulin lispro] or human insulin mix 50/50 [insulin neutral protamine lispro/insulin lispro]

Completed
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Insulin neutral protamine lispro/insulin lispro; Insulin suspension isophane/insulin
  • Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 05 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top